VRNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $89,626,516.96

Verona Pharma Insider Trading History Chart

Verona Pharma Share Price & Price History

^$22.43

▼ -0.31 (-1.36%)

As of 01/27/2023 01:00 AM ET

Days: 30 | 90 | 365

Is This The End of Capitalism?

From Porter & Company | Ad

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

click here now to get all the chilling details.

Verona Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/22/2022	Claire Poll	General Counsel	Sell	240,000	$2.69	$645,600.00	774,256
12/22/2022	Orbimed Advisors Llc	Director	Sell	3,969,496	$21.77	$86,415,927.92	36,255,896
12/20/2022	David Zaccardelli	CEO	Sell	600,000	$2.12	$1,272,000.00	17,775,800
8/9/2022	David Zaccardelli	CEO	Sell	600,000	$1.75	$1,050,000.00	15,263,560
8/2/2022	Kathleen A Rickard	Insider	Sell	28,752	$0.70	$20,126.40	2,376,040
8/1/2022	David Zaccardelli	CEO	Sell	32,904	$0.70	$23,032.80	15,863,560
8/1/2022	Mark W. Hahn	CFO	Sell	13,168	$0.70	$9,217.60	14,913,496
5/3/2022	David Zaccardelli	CEO	Sell	32,904	$0.50	$16,452.00	16,351,328
5/3/2022	Kathleen A Rickard	Insider	Sell	28,752	$0.49	$14,088.48	2,461,224
5/3/2022	Mark W. Hahn	CFO	Sell	12,512	$0.50	$6,256.00	15,381,520
4/11/2022	Kathleen A Rickard	Insider	Sell	59,720	$0.54	$32,248.80	2,546,408
4/8/2022	Kathleen A Rickard	Insider	Sell	112,800	$0.59	$66,552.00	2,606,128
2/3/2022	David Zaccardelli	CEO	Sell	52,056	$0.73	$38,000.88
2/2/2022	Mark W. Hahn	CFO	Sell	10,416	$0.76	$7,916.16
2/1/2022	Lisa Deschamps	Director	Sell	11,664	$0.78	$9,097.92
11/2/2021	David Zaccardelli	CEO	Sell	52,056	$0.64	$33,315.84
11/2/2021	Lisa Deschamps	Director	Sell	11,672	$0.66	$7,703.52
11/2/2021	Mark W. Hahn	CFO	Sell	10,416	$0.65	$6,770.40
8/3/2021	David Zaccardelli	CEO	Sell	16,000	$0.76	$12,160.00
8/2/2021	Mark W. Hahn	CFO	Sell	10,416	$0.77	$8,020.32	16,466,800
5/4/2021	Anders Ullman	Director	Sell	12,056	$0.84	$10,127.04
3/1/2021	David Zaccardelli	CEO	Sell	43,392	$1.14	$49,466.88
3/1/2021	Mark W. Hahn	CFO	Sell	26,728	$1.14	$30,469.92
2/1/2021	Anders Ullman	Director	Sell	10,800	$0.99	$10,692.00

The Next Big Crisis Is Here

From Porter & Company | Ad

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

Click here to watch it, free.

SEC Filings (Institutional Ownership Changes) for Verona Pharma (NASDAQ:VRNA)

Institutional Buying and Selling by Quarter

Verona Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
1/24/2023	Moody Aldrich Partners LLC	221,183	$5.78M	1.2%	-3.0%	0.292%
12/8/2022	Bank of New York Mellon Corp	24,850	$0.25M	0.0%	N/A	0.034%
11/16/2022	Glenmede Trust Co. NA	30,215	$0.31M	0.0%	N/A	0.042%
11/15/2022	State Street Corp	449,029	$4.23M	0.0%	N/A	0.617%
11/15/2022	Two Sigma Advisers LP	153,400	$1.57M	0.0%	N/A	0.211%
11/15/2022	Two Sigma Investments LP	360,550	$3.69M	0.0%	N/A	0.495%
11/15/2022	Vanguard Group Inc.	41,704	$0.43M	0.0%	N/A	0.057%
11/15/2022	Perceptive Advisors LLC	5,047,264	$51.58M	1.5%	+73.1%	6.936%
11/15/2022	Pura Vida Investments LLC	100,000	$1.02M	0.1%	N/A	0.137%
11/15/2022	Parkman Healthcare Partners LLC	323,273	$3.30M	0.9%	N/A	0.444%
11/15/2022	Bank of New York Mellon Corp	24,850	$0.25M	0.0%	N/A	0.034%
11/14/2022	NEA Management Company LLC	5,584,753	$57.08M	2.8%	+9.3%	7.675%
11/14/2022	Vivo Capital LLC	4,249,918	$43.43M	4.8%	+54.5%	5.840%
11/14/2022	Cubist Systematic Strategies LLC	42,877	$0.44M	0.0%	N/A	0.059%
11/14/2022	Renaissance Technologies LLC	210,100	$2.15M	0.0%	+645.0%	0.289%
11/14/2022	RA Capital Management L.P.	6,050,000	$61.83M	1.3%	+18.6%	8.314%
11/14/2022	Boothbay Fund Management LLC	46,799	$0.48M	0.0%	+22.3%	0.064%
11/14/2022	Altium Capital Management LP	404,000	$4.13M	1.5%	N/A	0.555%
11/14/2022	UBS Oconnor LLC	111,926	$1.14M	0.0%	N/A	0.154%
11/14/2022	Forefront Analytics LLC	13,446	$0.14M	0.1%	-50.6%	0.018%
11/10/2022	Envestnet Asset Management Inc.	16,192	$0.17M	0.0%	N/A	0.022%
11/10/2022	ExodusPoint Capital Management LP	239,602	$2.45M	0.0%	N/A	0.329%
11/9/2022	Fairmount Funds Management LLC	2,678,982	$27.38M	4.8%	+189.1%	3.681%
11/8/2022	AlphaCentric Advisors LLC	40,000	$0.41M	0.4%	N/A	0.055%
11/7/2022	D.A. Davidson & CO.	40,000	$0.41M	0.0%	-10.1%	0.055%
11/7/2022	Jump Financial LLC	40,800	$0.42M	0.0%	N/A	0.056%
11/3/2022	ACT Capital Management LLC	143,500	$1.47M	2.0%	N/A	0.197%
11/1/2022	Brinker Capital Investments LLC	12,326	$0.13M	0.0%	N/A	0.017%
10/27/2022	US Bancorp DE	46,095	$0.47M	0.0%	+1,100.4%	0.063%
10/18/2022	Moody Aldrich Partners LLC	227,989	$2.33M	0.5%	N/A	0.313%
8/18/2022	Goldman Sachs Group Inc.	11,593	$49K	0.0%	N/A	0.019%
8/16/2022	Woodline Partners LP	501,458	$2.10M	0.0%	N/A	0.823%
8/13/2022	Renaissance Technologies LLC	28,200	$0.12M	0.0%	N/A	0.047%
8/12/2022	Ikarian Capital LLC	300,000	$0.20M	0.0%	N/A	0.497%
8/10/2022	Forefront Analytics LLC	27,196	$0.11M	0.1%	-23.7%	0.045%
7/28/2022	D.A. Davidson & CO.	44,500	$0.19M	0.0%	-7.3%	0.074%
5/16/2022	Wellington Management Group LLP	3,778,785	$18.86M	0.0%	-21.8%	6.260%
5/12/2022	Citigroup Inc.	369,008	$1.84M	0.0%	N/A	0.611%
5/11/2022	GSA Capital Partners LLP	13,150	$66K	0.0%	N/A	0.022%
2/14/2022	Perceptive Advisors LLC	2,867,510	$19.27M	0.3%	-0.7%	4.776%
2/14/2022	IPG Investment Advisors LLC	11,900	$80K	0.0%	N/A	0.020%
1/31/2022	D.A. Davidson & CO.	48,000	$0.32M	0.0%	+20.0%	0.080%
1/18/2022	Lindbrook Capital LLC	10,000	$67K	0.0%	N/A	0.017%
11/16/2021	Wellington Management Group LLP	4,294,038	$23.53M	0.0%	+9.8%	7.152%
11/10/2021	Citigroup Inc.	495,446	$2.72M	0.0%	N/A	0.825%
11/9/2021	BlackRock Inc.	245,594	$1.35M	0.0%	-1.7%	0.409%
8/11/2021	Quantitative Systematic Strategies LLC	14,034	$92K	0.0%	-51.9%	0.024%
8/11/2021	Ghost Tree Capital LLC	1,000,000	$6.54M	1.8%	+6.5%	1.726%
8/2/2021	Chicago Partners Investment Group LLC	10,006	$58K	0.0%	N/A	0.017%
7/31/2021	Wedbush Securities Inc.	18,035	$0.12M	0.0%	-18.0%	0.031%
5/19/2021	venBio Partners LLC	161,897	$1.35M	0.1%	-18.7%	0.279%
5/17/2021	Schonfeld Strategic Advisors LLC	56,500	$0.47M	0.0%	+18.2%	0.098%
5/17/2021	Polar Capital Holdings Plc	1,000,000	$8.36M	0.1%	-38.5%	1.726%
5/17/2021	DAFNA Capital Management LLC	18,337	$0.15M	0.0%	-88.6%	0.032%
5/17/2021	Sphera Funds Management LTD.	801,256	$6.70M	0.5%	-22.5%	1.383%
5/17/2021	Novo Holdings A S	838,360	$7.01M	0.3%	-67.9%	1.447%
5/14/2021	Ghost Tree Capital LLC	939,043	$7.85M	1.8%	+15.9%	1.621%
5/13/2021	Forefront Analytics LLC	14,102	$0.12M	0.1%	N/A	0.024%
5/7/2021	D.A. Davidson & CO.	41,900	$0.35M	0.0%	-57.7%	0.072%
5/6/2021	Quantitative Systematic Strategies LLC	29,170	$0.24M	0.0%	N/A	0.050%
4/26/2021	Wedbush Securities Inc.	22,000	$0.18M	0.0%	+83.3%	0.038%
4/21/2021	Personal CFO Solutions LLC	10,000	$84K	0.0%	N/A	0.017%
3/26/2021	Susquehanna International Group LLP	12,037	$84K	0.0%	N/A	0.091%
2/25/2021	Hsbc Holdings PLC	15,041	$0.11M	0.0%	N/A	0.114%
2/18/2021	Ghost Tree Capital LLC	810,000	$5.67M	1.2%	+0.6%	6.152%
2/17/2021	IHT Wealth Management LLC	18,560	$0.13M	0.0%	-14.7%	0.141%
2/16/2021	HighVista Strategies LLC	26,681	$0.19M	0.1%	N/A	0.203%
2/10/2021	Renaissance Technologies LLC	24,800	$0.17M	0.0%	N/A	0.188%
2/10/2021	D.A. Davidson & CO.	98,951	$0.69M	0.0%	+13.2%	0.752%
11/19/2020	Schonfeld Strategic Advisors LLC	54,600	$0.34M	0.0%	N/A	0.415%
11/17/2020	Schonfeld Strategic Advisors LLC	54,600	$0.34M	0.0%	N/A	0.415%
11/17/2020	Polar Capital LLP	1,000,000	$6.24M	0.0%	N/A	7.595%
11/16/2020	Samsara BioCapital LLC	1,111,112	$6.93M	1.9%	+2,456.9%	8.439%
11/16/2020	Perceptive Advisors LLC	2,888,889	$18.03M	0.3%	N/A	21.942%
11/16/2020	Polar Capital LLP	1,000,000	$6.24M	0.0%	N/A	7.595%
11/16/2020	Abingworth LLP	2,457,499	$15.34M	3.3%	+172.5%	18.665%
11/13/2020	Vivo Capital LLC	3,048,507	$19.02M	1.1%	+104.2%	23.154%
11/13/2020	Foresite Capital Management III LLC	1,111,112	$6.93M	5.2%	N/A	8.439%
11/12/2020	Sphera Funds Management LTD.	1,000,000	$6.24M	0.6%	N/A	7.595%
11/6/2020	NEA Management Company LLC	5,108,563	$31.88M	1.3%	+318.8%	38.801%
11/2/2020	D.A. Davidson & CO.	87,385	$0.55M	0.0%	-25.2%	0.664%
10/20/2020	Wedbush Securities Inc.	43,300	$0.27M	0.0%	-60.3%	0.329%
8/10/2020	D.A. Davidson & CO.	116,810	$0.55M	0.0%	+34.7%	0.887%
7/16/2020	Wedbush Securities Inc.	109,100	$0.51M	0.0%	+53.8%	0.828%
5/18/2020	Vivo Capital LLC	1,492,951	$6.15M	0.6%	N/A	11.339%
5/18/2020	venBio Partners LLC	456,770	$1.88M	1.6%	-47.8%	3.469%
5/14/2020	Tekla Capital Management LLC	253,179	$1.04M	0.0%	-7.9%	1.923%
5/5/2020	D.A. Davidson & CO.	86,730	$0.36M	0.0%	N/A	0.659%
4/23/2020	Clear Creek Financial Management LLC	37,500	$0.17M	0.1%	N/A	0.285%
4/17/2020	Wedbush Securities Inc.	70,950	$0.29M	0.0%	-12.5%	0.539%
2/14/2020	UBS Group AG	10,055	$58K	0.0%	+801.8%	0.076%
2/13/2020	Renaissance Technologies LLC	12,500	$72K	0.0%	N/A	0.095%
1/16/2020	Wedbush Securities Inc.	81,100	$0.47M	0.0%	+167.5%	0.616%
11/27/2019	IHT Wealth Management LLC	20,460	$94K	0.0%	+18.1%	0.155%
10/17/2019	Wedbush Securities Inc.	30,315	$0.14M	0.0%	+24.7%	0.230%
4/17/2019	Wedbush Securities Inc.	24,800	$0.16M	0.0%	+75.5%	0.189%
2/13/2019	Foresite Capital Management III LLC	206,663	$1.99M	0.7%	-58.7%	1.574%
2/8/2019	Aisling Capital Management LP	443,596	$4.28M	4.5%	N/A	3.378%
1/31/2019	Wedbush Securities Inc.	14,130	$0.13M	0.0%	N/A	0.108%
11/13/2018	Foresite Capital Management IV LLC	8,302	$0.10M	0.0%	N/A	0.063%

Data available starting January 2016

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $22.43

$22.04

$23.18

50 Day Range

MA: $18.80

$12.18

$26.13

52 Week Range

Now: $22.43

$3.41

$26.44

Volume

930,322 shs

Average Volume

621,027 shs

Market Capitalization

$1.70 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.15

Who are the company insiders with the largest holdings of Verona Pharma?: Verona Pharma's top insider shareholders include:
Orbimed Advisors Llc (Director)
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
Claire Poll (General Counsel)
Anders Ullman (Director)
Lisa Deschamps (Director)
Mark W Hahn (CFO)
Patrick John Finn (Insider)
Learn More about top insider investors at Verona Pharma.
Who are the major institutional investors of Verona Pharma?: Verona Pharma's top institutional investors include:
Moody Aldrich Partners LLC — 0.29%
Learn More about top institutional investors of Verona Pharma stock.
Which major investors are selling Verona Pharma stock?: Within the previous quarter, VRNA stock was sold by these institutional investors:
Moody Aldrich Partners LLC
Within the last year, company insiders that have sold Verona Pharma company stock include:
Orbimed Advisors Llc (Director)
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
Claire Poll (General Counsel)
Anders Ullman (Director)
Learn More investors selling Verona Pharma stock.